Concepedia

Christopher E. Mahoney

CE

10

Publications

1.7K

Citations

10

H-Index

2009

Active since

Affiliations

Agios Pharmaceuticals (United States)(Current)

Brigham and Women's Hospital

Harvard University

Christopher E. Mahoney is an author at Agios Pharmaceuticals (United States) specializing in medicine, biochemistry, and neuro-oncology.

ORCID

Top concepts

Publications per year

2009–2020

10

Publications

10

MicroRNA-210 Controls Mitochondrial Metabolism during Hypoxia by Repressing the Iron-Sulfur Cluster Assembly Proteins ISCU1/2

Stephen Y. Chan, Yingyi Zhang, Craig Hemann et al. · Cell Metabolism · 2009 · 695 citations · Full text

, , +10

Aldosterone Inactivates the Endothelin-B Receptor via a Cysteinyl Thiol Redox Switch to Decrease Pulmonary Endothelial Nitric Oxide Levels and Modulate Pulmonary Arterial Hypertension

Bradley A. Maron, Yingyi Zhang, Kevin P. White et al. · Circulation · 2012 · 196 citations · Full text

Glutathione Peroxidase-3 Deficiency Promotes Platelet-Dependent Thrombosis In Vivo

Richard C. Jin, Christopher E. Mahoney, Laura Anderson et al. · Circulation · 2011 · 182 citations · Full text

Bone Morphogenetic Protein‐2 Decreases MicroRNA‐30b and MicroRNA‐30c to Promote Vascular Smooth Muscle Cell Calcification

Joshua Balderman, Hae‐Young Lee, Christopher E. Mahoney et al. · Journal of the American Heart Association · 2012 · 146 citations · Full text

Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase

Anil K. Padyana, Lei Jin, Giovanni Cianchetta et al. · Nature Communications · 2019 · 146 citations · Full text

Rows per page

1–5 of 10